Table 1 Characteristics of patients at ICU admission
From: Galectin-3 in septic acute kidney injury: a translational study
Variable | All patients (n = 57) | Patients without subsequent AKI (n = 30) | Patients with subsequent AKI (n = 27) | P value |
|---|---|---|---|---|
Age (years) | 59 (53–66) | 59 (53–66.8) | 61 (55–66) | 0.53 |
Female sex, n (%) | 32 (56) | 18 (60) | 14 (52) | 0.73 |
ICU stay (days) | 13 (9–15) | 11 (8.3–13) | 15 (11.5–19.5) |  < 0.001 |
APACHE II score | 16 (12–21) | 14 (11–17) | 20 (13.5–23) |  < 0.05 |
Serum Gal-3 (ng/ml) | 5.7 (3.6–8.9) | 4.2 (3.5–7) | 7.9 (4.7–16.6) | 0.002 |
Serum CysC (μg/ml) | 1.5 (1.1–2.2) | 1.2 (0.9–1.5) | 2 (1.7–4.1) | 0.002 |
Serum NGAL (ng/ml) | 302.9 (175.3–514.2) | 243.4 (170.6–421.9) | 430 (215–561) | 0.406 |
Serum PCT (ng/ml) | 11.2 (3.1–52.4) | 7.7 (2.9–27.3) | 32.6 (3.7–91) | 0.007 |